Autologous fat grafting, also known as lipofilling, is a surgical technique consisting in the processing and transfer of adipose tissue from one area in our organism (hips, thighs) to region which in need of reconstructive and aesthetic correction. The technique is frequently used after radical or conservative mammary surgery, aiming to achieve better aesthetic results, reduce pain induced by both surgery and radiotherapy. The scientific community was widely involved in the debate regarding the use of mesenchymal/stem cells in a patient with high risk of tumor progression due to their elevated proliferative profile. This study aims to retrospectively evaluate the oncological safety in the use of lipofilling in patients who underwent oncological and reconstructive treatment in our Institute.
Study Type
OBSERVATIONAL
Enrollment
6,510
Surgical intervention based on the injection of autologous fat grafting after radical or conservative breast surgery and breast reconstruction.
Breast reconstructive procedures after oncological radical or conservative breast surgery
Istituto Clinico Humanitas
Rozzano, Milan, Italy
Oncological safety of autologous fat grafting
Percentage of disease relapse in loco
Time frame: Two years
Establishment of timing in disease relapse
Time frame: Two years
Establish the distribution in disease relapses
Establish the distribution in disease relapse in thre different histological subtypes of breast carcinoma
Time frame: Two years
Establish overall survival rate in experimental and control groups
Time frame: Two years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.